GREENPLYNSEGreenply Industries Limited· Consumer DurablesHighNeutral
Announced Wed, 4 Feb, 2026 · 14:27 IST

Greenply Q3 FY26 results: revenue up, profit down; INR 425 cr MDF expansion approved

GREENPLY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-5.3%Reaction day
₹235.60
prior close
₹229.97
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+1.3%-6.7% vs market
Plywood Boards/ Laminates peers, median of 11sector+0.1%-5.5% vs sector

On the reaction day the stock moved 6.7 pts less than Nifty Microcap 250 and 5.5 pts less than its Plywood Boards/ Laminates peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.2
10m
-0.9
15m
-1.3
30m
-2.4
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-5.3+1.3-6.7+0.1-5.5
Next day
-6.2+0.3-6.5-0.2-6.1
2d
-3.6-0.5-3.1+0.0-3.6
3d
+2.4+2.1+0.3-0.3+2.7
4d
+1.4+3.1-1.7+1.1+0.3
5d
+0.5+2.6-2.1-0.0+0.5
1w
-3.4+0.6-4.0-0.8-2.6
15d
-4.7-1.4-3.3-5.3+0.6
1m
-10.9-6.9-4.0-8.5-2.4
2m
-17.2-7.7-9.5-11.9-5.3
3m
+12.6+7.0+5.6-2.2+14.7
UpDownMarket · Nifty Microcap 250Sector · Plywood Boards/ Laminates peers, median of 11Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Greenply Q3 FY26 standalone revenue rose 8.3 percent YoY to Rs 500.54 cr but PAT fell 26 percent to Rs 17.98 cr. Consolidated revenue was Rs 673.40 cr with PAT at Rs 14.34 cr. Nine-month consolidated PAT dropped about 32 percent. An exceptional item of Rs 3.40 cr (standalone) and Rs 3.85 cr (consolidated) was booked for new Labour Codes impact. Board approved INR 425 cr MDF capacity expansion at the Vadodara subsidiary plant, adding 600-700 CBM per day by Q2 FY28, funded via INR 125 cr equity infusion plus borrowings. Limited review by BSR and Co LLP was unmodified.

Likely market impact

Profit decline is a worry despite revenue growth. Large capex signals growth push but adds funding and execution risk over the next two to three years.